Work

Ivonescimab (ivo) with oxaliplatin + fluorouracil (5-FU) + leucovorin calcium (mFOLFOX6) for patients (pts) with unresectable metastatic colorectal cancer (mCRC): A phase 2 study.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.3576

Authors: David Berz, Yanhong Deng, Jianwei Zhang, Zhiwei Li, Ming Yin, Junjie Zhao, Karl Albert Eckert, Nindhana Paranthaman, Xufang Yu, Yu Xia, Alexander I. Spira

Institutions: Sun Yat-sen University, Sixth Affiliated Hospital of Sun Yat-sen University, Third Affiliated Hospital of Harbin Medical University, Virginia Cancer Specialists

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162554491

Cites:

Cited by: 1

Related to: